GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review

Disease-A-Month · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles